Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.

RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

Open access
Madhu, SV, Chawla, Rajeev, Makkar, BM, Ghosh, Sujoy, Saboo, Banshi, Kalra, Sanjay · 2020 · Indian Journal of Endocrinology and Metabolism

Abstract

DIAGNOSIS OF DIABETES RECOMMENDATIONSTable: No title available.Table: No title available.NOTE Estimation of HbA1c should be performed using NGSP standardized method. Capillar y glucose estimation methods are not recommended for diagnosis Venous plasma is used for estimation of glucose Plasma must be separated soon after collection because the blood glucose levels drop by 5%–8% hourly if whole blood is stored at room temperature. For more details on glucose estimation visit: http://www.ncbi.nlm.nih.gov/books/NBK248/ *FPG is defined as glucose estimated after no caloric intake for at least 8–12 hours. **Using a method that is National Glycohaemoglobin Standardization Program (NGSP) certified. For more on HbA1c and NGSP, please visit http://www.ngsp.org/index.asp BACKGROUND The diagnostic criteria of diabetes have been constantly evolving. Both type 1 and type 2 Diabetes mellitus (DM) are diagnosed based on the plasma glucose criteria, either the fasting plasma glucose (FPG) levels or the 2-h plasma post-prandial glucose (2-h PPG) levels during a 75-g oral glucose tolerance test (OGTT), or the newer glycosylated haemoglobin (HbA1c) criteria which reflects the average plasma glucose concentration over the previous 8–12 weeks.[12] The International Expert Committee Report recommend a cut-point of ≥6.5% for HbA1c for diagnosing diabetes as an alternative to fasting plasma glucose (FPG ≥7.0 mmol/L).[3] HbA1c testing has some substantial advantages over FPG and OGTT, such as convenience, pre-analytical stability, and less day-to-day fluctuations due to stress and illness.[3] Additionally, HbA1c has been recognized as marker to assess secondary vascular complications due to metabolic derailments in susceptible individuals.[245] However, given ethnic differences in sensitivity and specificity of HbA1c population-specific cut-offs might be necessary.[67] Moreover, measuring HbA1c is expensive as compared to FPG assessments and standardization of measurement techniques and laboratories are poorly practiced across the country.[8] Also, in several countries including India, HbA1c demonstrated inadequate predictive accuracy in the diagnosis of diabetes, there is no consensus on a suitable cut-off point of HbA1c for diagnosis of diabetes in this high-risk population.[9] In lieu of this, the panel expressed concerns on using HbA1c as sole criteria for diagnosis of diabetes particularly in resource constraint settings. Therefore, a combination of HbA1cand FPG would improve the identification of individuals with diabetes mellitus and prediabetes in limited resource settings like India. CONSIDERATIONS The decision about setting diagnostic thresholds values was based on the cost-effective strategies for diagnosing diabetes that were reviewed in Indian context. RATIONALE AND EVIDENCE Glycosylated haemoglobin cut off for diagnosis of diabetes in Indian patients The RSSDI expert panel suggests [WHITE SMALL SQUAREHbA1c ≥6.5% as optimal level for diagnosis of diabetes in Indian patients [WHITE SMALL SQUAREHbA1c cannot be used as 'sole' measurement for diagnosis of diabetes in Indian settings. These recommendations are based on the Indian evidences A recent study conducted in Singapore residents of Chinese, Malay and Indian race to assess the performance of HbA1c as a screening test in Asian populations suggested that HbA1c is an appropriate alternative to FPG as a first-step screening test, and a combination of HbA1c with a cut-off of ≥6.1% and FPG level ≥100 mg/dL would improve detection in patients with diabetes.[6] A study to assess the diagnostic accuracy and optimal HbA1c cutoffs for diabetes and prediabetes among high-risk south Indians suggested that HbA1c ≥6.5% can be defined as a cut-off for diabetes and HbA1c ≥5.9% is optimal for prediabetes diagnosis and value <5.6% excludes prediabetes/diabetes status.[8] Data from a community based randomized cross sectional study in urban Chandigarh suggest that HbA1c cut point of 6.5% has optimal specificity of 88%, while cut off point of 7.0% has sensitivity of 92% for diagnosis of diabetes.[10] The results of the Chennai Urban Rural Epidemiology Study (CURES) demonstrated 88.0% sensitivity and 87.9% specificity for detection of diabetes when HbA1c cut off point is 6.1% (based on 2-h post load plasma glucose) and 93.3% sensitivity and 92.3% specificity when HbA1c cut off point is 6.4% (when diabetes was defined as FPG ≥7.0 mmol/l).[11] However, panel emphasized that HbA1c can be used in settings where an appropriate standardized method is available. IMPLEMENTATION Individuals should be educated on the advantages of early diagnosis and should be encouraged to participate in community screening programs for diagnosis. PREVENTION RECOMMENDATIONSTable: No title available.Table: No title available.BACKGROUND Chronic hyperglycaemia is associated with significantly higher risk of developing diabetes related micro-and macrovascular complications. Early detection of diabetes/prediabetes throu

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/ijem.ijem_225_20

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 174 references

Cited by

See all 167

Metadata

Authors
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S.
Venue
Indian Journal of Endocrinology and Metabolism
Publisher
Medknow
Published
2020
Volume
24
Issue
1
Pages
1
ISSN
2230-8210 (ISSN-L)
OpenAlex
W3023689184
Cited by
167
References
174
FWCI
17.20
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. https://app.cochat.ai/papers/10.4103/ijem.ijem_225_20
The paper
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020). RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian Journal of Endocrinology and Metabolism. https://doi.org/10.4103/ijem.ijem_225_20

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.